Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 5/20 | 0.49 |
| ▸ | FAAH | O00519 | 3/20 | 0.49 |
| ▸ | RXRA | P19793 | 2/20 | 0.48 |
| ▸ | RXRB | P28702 | 2/20 | 0.48 |
| ▸ | RXRG | P48443 | 2/20 | 0.48 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28349233 | 0.92 | MGLL (0.44) | MGLLFAAHRXRARXRBRXRG | |
| SCHEMBL514697 | 0.89 | MGLL (0.59) | MGLLFAAHRXRARXRBRXRG | |
| Hydrochloric Acid SCHEMBL28737900 | 0.87 | MGLL (0.58) | MGLLFAAHRXRARXRBRXRG | |
| Hydrazine SCHEMBL27822007 | 0.86 | MGLL (0.56) | MGLLFAAHRXRARXRBRXRG | |
| SCHEMBL8510655 | 0.84 | MGLL (0.49) | MGLLFAAHRXRARXRBRXRG | |
| SCHEMBL2347571 | 0.82 | MGLL (0.40) | MGLLFAAHRXRARXRBRXRG | |
| SCHEMBL1823484 | 0.80 | PPARD (0.62) | MGLLFAAHMAPK1PPARDPPARA | |
| SCHEMBL20053772 | 0.79 | RXRA (0.56) | RXRARXRBRXRGTBXAS1HDAC3 | |
| SCHEMBL741572 | 0.77 | MGLL (0.59) | MGLLFAAHRXRARXRBRXRG | |
| Phenylbutanoic Acid SCHEMBL22157891 | 0.77 | HDAC3 (0.53) | HDAC3MAPK1ADRA1AHDAC4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 497 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743076-A2 | SYNTHETIC BI-FUNCTIONAL DEGRADERS OF INTEGRINS | The Board of Trustees of the Leland Stanford Junior University (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-3600372-B1 | SYNTHEKINE COMPOSITIONS AND METHODS OF USE | UNIV LELAND STANFORD JUNIOR (US) | 2026-05-13 | — | — | EP | disclosed |
| EP-4739804-A1 | METHODS AND COMPOSITIONS FOR CHARACTERIZING VIRAL PARTICLES IN A BIOLOGICAL SAMPLE | NanoMosaic Inc. (US) | 2026-05-13 | — | — | EP | disclosed |
| US-20260108469-A1 | COMPOSITIONS COMPRISING WATER INSOLUBLE DRUGS AND METHODS OF PRODUCING AND USING SAME | NANO GHOST LTD (IL) | 2026-04-23 | — | — | US | disclosed |
| US-20260091143-A1 | NEAR-INFRARED IMAGING AGENT AND USES THEREOF | UNIV CASE WESTERN RESERVE (US) | 2026-04-02 | — | — | US | disclosed |
| US-12466884-B2 | Tissue-specific WNT signal enhancing molecules and uses | Surrozen Operating, Inc. (US) | 2025-11-11 | — | — | US | disclosed |
| US-12453762-B2 | Complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist for treatment of glioblastoma | AMAL THERAPEUTICS SA (CH) | 2025-10-28 | — | — | US | disclosed |
| US-20250304702-A1 | WNT SIGNALING AGONIST MOLECULES | UNIVERSITY OF WASHINGTON | 2025-10-02 | — | — | US | disclosed |
| US-20250250329-A1 | CYTOKINE ADAPTOR PROTEINS AND USES THEREOF | HOWARD HUGHES MEDICAL INSTITUTE | 2025-08-07 | — | — | US | disclosed |
| EP-4590179-A1 | NEAR-INFRARED IMAGING AGENT AND USES THEREOF | CASE WESTERN RESERVE UNIVERSITY (US) | 2025-07-30 | — | — | EP | disclosed |
| US-5869040-A | ADMINISTERING INTERFERING MUTANT PROTO-ONCOGENE OR ONCOPROTEIN TO TARGET CELL | BIOGEN, INC (US) | 1999-02-09 | — | — | US | disclosed |
| EP-0656950-B1 | TAT-DERIVED TRANSPORT POLYPEPTIDES | BIOGEN INC (US) | 1998-11-04 | — | — | EP | disclosed |
| US-5804604-A | AGENT FOR INTRACELLULAR DELIVERY OF CARGO MOIETY | BIOGEN, INC. (US) | 1998-09-08 | — | — | US | disclosed |
| US-5747641-A | CARGO MOLECULE CONJUGATED TO TRANSPORT POLYPEPTIDE HAVING ABSENCE OF CYSTEINE RICH POLYPEPTIDE REGIONS FOR REDUCED DISULFIDE AGGREGATION AND TRANS-ACTIVATION; INTRACELLULAR DELIVERY | BIOGEN MA INC. | 1998-05-05 | — | — | US | disclosed |
| WO-1997034473-A9 | CRAF1 (TRAF-3) ISOFORMS AND USES THEREOF | — | 1998-04-02 | — | — | WO | disclosed |
| WO-1997043416-A1 | COMMON GAMMA CHAIN BLOCKING AGENTS | BIOGEN, INC. (US) | 1997-11-20 | — | — | WO | disclosed |
| US-5674980-A | Fusion protein comprising tat-derived transport moiety | BIOGEN IDEC MA, INC. | 1997-10-07 | — | — | US | disclosed |
| WO-1997034473-A1 | CRAF1 (TRAF-3) ISOFORMS AND USES THEREOF | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1997-09-25 | — | — | WO | disclosed |
| US-5670617-A | PROTEINS AND SINGLE-STRANDED OR DOUBLE STRANDED NUCLEIC ACID | BIOGEN IDEC MA, INC. | 1997-09-23 | — | — | US | disclosed |
| US-5652122-A | Nucleic acids encoding and methods of making tat-derived transport polypeptides | BIOGEN IDEC MA, INC. | 1997-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260108469-A1 | COMPOSITIONS COMPRISING WATER INSOLUBLE DRUGS AND METHODS OF PRODUCING AND USING SAME | ABCB1, WEE1, PARP3 | MGLL 3818/4885FAAH 4554/4885RXRA 4462/4885 |
| US-20250250329-A1 | CYTOKINE ADAPTOR PROTEINS AND USES THEREOF | IL6ST, TNFRSF1A, TRAF6 | MGLL 4166/4885FAAH 3763/4885RXRA 2860/4885 |
| US-20260091143-A1 | NEAR-INFRARED IMAGING AGENT AND USES THEREOF | IGSF11, VSIR, FCGR3B | MGLL 1494/4885FAAH 2469/4885RXRA 1636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.